Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

sultopride

Known as: N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide, N-(ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
BACKGROUND Antipsychotic agents are often used to treat neuropsychiatric symptoms (NPS) in dementia, although the literature is… Expand
  • figure 2
  • table 2
  • table 1
  • table 2
2011
2011
In Lambert–Eaton myasthenic syndrome (LEMS), antibodies against presynaptic voltage-gated calcium channels reduce the quantal… Expand
  • figure 1
  • table 1
  • table 2
2006
2006
Conventional antipsychotics tend to elicit extrapyramidal symptoms at clinical doses, but dose optimization could reduce the risk… Expand
Highly Cited
2005
Highly Cited
2005
Recent neuroimaging studies have demonstrated abnormal central emotional processing in psychiatric disorders. The dopamine (DA… Expand
Highly Cited
1988
Highly Cited
1988
The in‐vitro selectivity of a group of substituted benzamide drugs for brain neurotransmitter receptors was determined to assess… Expand
Highly Cited
1986
Highly Cited
1986
Dopamine receptor blockade by pimozide has previously been shown to reduce the intake of pellets and of a sweet solution by… Expand
1985
1985
A high-performance liquid chromatographic method with UV detection (226 nm) for the analysis of sulpiride and sultopride in body… Expand
1982
1982
The binding of [3H]sultopride, a benzamide drug, to rat brain was investigated in vitro. Specific [3H]sultopride binding was… Expand
Highly Cited
1978
Highly Cited
1978
The effects of 6 benzamides and 8 classical neuroleptics were studied on 6 different apomorphine-induced effects. These drugs did… Expand